Sight Sciences Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
SGHT Nasdaq 3841 https://www.sightsciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sight Sciences Inc

Sight Sciences Two Year Multicenter Study Results Show Sustained Reductions in Both Intraocular Pressure (IOP) and Glaucoma Medication Use in Mild-Moderate Primary Open Angle Glaucoma Patients Treated with a Procedure Enabled with the OMNI® Surgical System Technology - May 23rd, 2023 12:30 pm
How Much Upside is Left in Sight Sciences, Inc. (SGHT)? Wall Street Analysts Think 38.78% - May 9th, 2023 1:55 pm
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma Surgery (MIGS) Comparative Analysis of Real-World Data (RWD) from the American Academy of Ophthalmology IRIS® Registry - May 6th, 2023 3:30 pm
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Misses Revenue Estimates - May 4th, 2023 10:45 pm
Sight Sciences Reports First Quarter 2023 Financial Results and Reaffirms Guidance for Full Year 2023 - May 4th, 2023 8:05 pm
Sight Sciences' Glaucoma and Dry Eye Technologies to be Featured in Multiple Clinical Presentations at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - May 1st, 2023 8:05 pm
Sight Sciences to Present at the Upcoming Bank of America Securities 2023 Health Care Conference - Apr 26th, 2023 8:05 pm
Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023 - Apr 20th, 2023 8:05 pm
Why Investors Shouldn't Be Surprised By Sight Sciences, Inc.'s (NASDAQ:SGHT) P/S - Apr 19th, 2023 5:57 pm
Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023 - Apr 13th, 2023 8:05 pm
Strength Seen in Sight Sciences, Inc. (SGHT): Can Its 5.6% Jump Turn into More Strength? - Apr 11th, 2023 9:22 am
Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer - Apr 3rd, 2023 8:05 pm
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office - Mar 30th, 2023 12:00 pm
Owning 30% shares,institutional owners seem interested in Sight Sciences, Inc. (NASDAQ:SGHT), - Mar 23rd, 2023 3:25 pm
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2022 Earnings Call Transcript - Mar 14th, 2023 3:22 pm
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates - Mar 13th, 2023 9:25 pm
Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results - Mar 13th, 2023 8:05 pm
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System - Mar 9th, 2023 1:30 pm
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023 - Feb 23rd, 2023 9:05 pm
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference - Feb 22nd, 2023 9:05 pm